FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Prosor Maya
2. Date of Event Requiring Statement (Month/Day/Year)
02/21/2024		 3. Issuer Name and Ticker or Trading Symbol
Lemonade, Inc. [LMND]
(Last)
(First)
(Middle)
C/O LEMONADE, INC., 5 CROSBY STREET, 3RD FLOOR		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Business Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)

NEW YORK, NY 10013		 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
COMMON STOCK 79,286
I (1)
Directly held by Cohen Holdings, LLC
COMMON STOCK 927
D
 
COMMON STOCK 1,309 (2)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(Month/Day/Year) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
STOCK OPTION   (3) 12/01/2029 COMMON STOCK 80,000 $ 23.69 D  
STOCK OPTION   (4) 02/07/2033 COMMON STOCK 100,000 $ 18.17 D  
STOCK OPTION   (5) 04/05/2032 COMMON STOCK 49,800 $ 27.35 D  
STOCK OPTION   (6) 08/11/2033 COMMON STOCK 83,700 $ 15.13 D  
STOCK OPTION   (7) 09/02/2031 COMMON STOCK 28,500 $ 79.3 D  
STOCK OPTION   (8) 07/14/2032 COMMON STOCK 65,000 $ 19.03 D  
STOCK OPTION   (9) 12/06/2031 COMMON STOCK 14,800 $ 44.57 D  
STOCK OPTION   (10) 03/10/2031 COMMON STOCK 5,000 $ 94.07 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Prosor Maya
C/O LEMONADE, INC.
5 CROSBY STREET, 3RD FLOOR
NEW YORK, NY 10013		       Chief Business Officer  

Signatures

/s/ Timothy Bixby, Attorney-in-Fact for Maya Prosor 03/04/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Reporting Person is the owner of Cohen Holdings, LLC and has voting and dispositive control over the shares held by Cohen Holdings, LLC.
(2) This number represents restricted stock units that vest in 16 quarterly installments that began on September 1, 2021, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. These 1,309 shares are the remaining restricted stock units to vest beginning on March 1, 2024. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
(3) The option is fully vested and exercisable.
(4) The options vest in 16 quarterly installments which began on December 1, 2022. The option is vested and exercisable as to 25,000 shares.
(5) The options vest in 16 quarterly installments which began on April 5, 2022. The option is vested and exercisable as to 21,791 shares.
(6) The options vest in 16 quarterly installments which began on August 7, 2023. The option is vested and exercisable as to 10,464 shares.
(7) The options vest in 16 quarterly installments which began on September 1, 2021. The option is vested and exercisable as to 16,033 shares.
(8) The options vest in 16 quarterly installments which began on July 14, 2022. The option is vested and exercisable as to 24,378 shares.
(9) The options vest in 16 quarterly installments which began on December 6, 2021. The option is vested and exercisable as to 7,400 shares.
(10) The options vest in 16 quarterly installments which began on March 10, 2021. The option is vested and exercisable as to 3,440 shares.
 
Remarks:
Exhibit 24 - Power of Attorney.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.